Fosun International’s Ligand Pharmaceuticals LGND Stock Holding History

Fosun International’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,809	Closed	-$349K	–	141
2022 Q1	$349K	Hold	4,809	–	–	0.03%	164
2021 Q4	$489K	Hold	4,809	–	–	0.03%	166
2021 Q3	$420K	Hold	4,809	–	–	0.02%	164
2021 Q2	$405K	Hold	4,809	–	–	0.02%	156
2021 Q1	$447K	Hold	4,809	–	–	0.04%	139
2020 Q4	$296	Hold	4,809	–	–	0.02%	169
2020 Q3	$287K	Hold	4,809	–	–	0.03%	164
2020 Q2	$339K	Hold	4,809	–	–	0.03%	157
2020 Q1	$214K	Hold	4,809	–	–	0.02%	172
2019 Q4	$321K	Hold	4,809	–	–	0.03%	187
2019 Q3	$297K	Hold	4,809	–	–	0.03%	187
2019 Q2	$342K	Hold	4,809	–	–	0.02%	246
2019 Q1	$371K	Hold	4,809	–	–	0.02%	242
2018 Q4	$411K	Hold	4,809	–	–	0.02%	234
2018 Q3	$822K	Buy	+4,809	New	+$725K	0.04%	158

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Fosun International's LGND Position: Q2 2022 in Review

Fosun International sold out of Ligand Pharmaceuticals (LGND) in Q2 2022, closing a stake of 4,809 shares — an estimated $349K sold.

Fosun International first reported a position in LGND in Q3 2018 and held it in 15 quarters. The position peaked at $822K in Q3 2018. 197 funds tracked by Wall St. Rank hold LGND as of Q2 2022.

Fosun International reported no remaining Ligand Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Fosun International sold 4,809 Ligand Pharmaceuticals shares in Q2 2022, an estimated $349K.
Fosun International first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 15 quarters.
Fosun International's Ligand Pharmaceuticals position peaked at $822K in Q3 2018.
197 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2022.

Based on Fosun International's 13F filing for Q2 2022, filed 10 Aug 2022.